Incyte Payment for contingent consideration liability (financing) decreased by 7.6% to $4.96M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.6%, from $5.37M to $4.96M. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates that acquired businesses are hitting performance targets, which may lead to future growth but requires immediate cash outflows.
This metric represents cash payments made to settle liabilities related to earn-outs or performance-based milestones fro...
Specific to companies with active M&A strategies; peers in the semiconductor industry often report these as part of acquisition-related financing activities.
abbv_payment_contingent_consideration_financing| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.99M | $5.99M | $5.99M | $5.99M | $5.49M | $5.49M | $5.49M | $5.49M | $5.37M | $4.96M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -8.4% | +0.0% | +0.0% | +0.0% | -2.2% | -7.6% |
| YoY Change | — | — | — | — | -8.4% | -8.4% | -8.4% | -8.4% | -2.2% | -7.6% |